Lyons, Suzi (2010) Lapse and relapse following inpatient treatment of opiate dependence. Drugnet Ireland, Issue 35, Autumn 2010, pp. 21-22.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Drugnet Ireland issue 35)
- Published Version
1MB |
A study published in 2010 (1) examined the factors associated with lapse and relapse (2) in a prospective follow-up study of opiate users who had been admitted to an Irish residential detoxification facility between June 1995 and December 1996. Follow-up interviews were conducted by out-reach workers between June 1998 and March 1999.
|
Characteristic
|
Odds ratio
|
95% CI
|
P value
|
|
|
|
|
|
|
Age
|
|
|
|
|
Under 20
|
1.0
|
|
|
|
20 to 24
|
0.5
|
0.3 – 0.8
|
0.007
|
|
25 and over
|
0.6
|
0.4 – 1.1
|
0.11
|
|
|
|
|
|
|
Status of partner/spouse
|
|
|
|
|
Partner has history of opiate use
|
1.0
|
|
|
|
Partner has not used opiates/no partner
|
1.7
|
1.0 – 2.7
|
0.04
|
|
|
|
|
|
|
Quantity of heroin used
|
|
|
|
|
Up to 1.5 ‘quarters’ per day
|
1.0
|
|
|
|
1.5 to 3 ‘quarters’ per day
|
2.2
|
1.2 – 3.9
|
0.008
|
|
More than 3 ‘quarters’ per day
|
1.4
|
0.7 – 2.5
|
0.3
|
|
|
|
|
|
|
Imprisonment
|
|
|
|
|
Never in prison
|
1.0
|
|
|
|
In prison
|
1.4
|
0.9 – 2.3
|
0.15
|
|
|
|
|
|
|
History of injecting drug use
|
|
|
|
|
No injecting
|
1.0
|
|
|
|
Injecting previously
|
1.8
|
1.0 – 3.3
|
0.05
|
|
|
|
|
|
|
Type of discharge
|
|
|
|
|
Planned
|
1.0
|
|
|
|
Unplanned
|
2.6
|
1.6 – 4.4
|
<0.001
|
|
|
|
|
|
|
Aftercare
|
|
|
|
|
None
|
1.0
|
|
|
|
Commenced aftercare
|
1.7
|
1.1 – 2.8
|
0.03
|
This study, based on data collected in the late 1990s, found that lapse and relapse occurred very soon after opiate detoxification: 80% of participants had lapsed within the first month. The study findings are similar to those of international studies based on more recent data. The authors recommend that clients should be provided with improved psychological supports both before and after entering residential opiate detoxification. These include encouraging clients to remain for the full treatment period, improving relapse prevention supports, especially during the first week after discharge, and providing prompt access to aftercare.
HJ Treatment or recovery method > Substance disorder treatment method
VA Geographic area > Europe > Ireland
J Health care, prevention, harm reduction and treatment > Residential facility
J Health care, prevention, harm reduction and treatment > Rehabilitation
B Substances > Opioids (opiates)
Repository Staff Only: item control page